Yoshio Nakamura

发表

Hepatocyte growth factor as a potential index of complication in diabetes mellitus

T. Ogihara, R. Morishita, J. Higaki, 1998, Journal of hypertension.

Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).

K. Hirata, K. Tsuda, Yoshio Nakamura, 2011, Journal of atherosclerosis and thrombosis.

The MUSCAT Study: A Multicenter PROBE Study Comparing the Effects of Angiotensin II Type-1 Receptor Blockers on Self-Monitored Home Blood Pressure in Patients with Morning Hypertension: Study Design and Background Characteristics

H. Makino, Yoshio Nakamura, M. Kaihara, 2008, Hypertension Research.

Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.

K. Hirata, K. Tsuda, Y. Seino, 2008, Journal of atherosclerosis and thrombosis.

Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

T. Ogihara, R. Morishita, J. Higaki, 1996, Journal of hypertension.

Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy.

H. Sugiyama, Y. Maeshima, H. Makino, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Remission and regression of diabetic nephropathy.

H. Makino, Yoshio Nakamura, J. Wada, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus

H. Makino, Yoshio Nakamura, M. Kaihara, 2010, Journal of diabetes investigation.

Title Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus : A 52-week , multicenter , parallel-group randomized controlled trial

T. Nakayama, N. Inagaki, N. Harada, 2018 .

A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure

Takashi Suzuki, H. Sasano, Yoshio Nakamura, 2003, Endocrine.

Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).

Yoshio Nakamura, Y. Hamamoto, S. Honjo, 2009, Diabetes research and clinical practice.

The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.

N. Minamino, K. Kangawa, H. Makino, 2004, Kidney international.

Role of bradykinin in renoprotective effects by angiotensin II type 1 receptor antagonist in salt-sensitive hypertension.

F. Otsuka, H. Makino, Yoshio Nakamura, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

EFFECT OF AN ANTIHYPERTENSIVE DRUG ON BRAIN ANGIOTENSIN II LEVELS IN RENAL AND SPONTANEOUSLY HYPERTENSIVE RATS

T. Ogihara, R. Morishita, J. Higaki, 1995, Clinical and experimental pharmacology & physiology.

Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats.

H. Makino, Yoshio Nakamura, M. Kaihara, 2009, Acta medica Okayama.

Plasma Orexin Concentrations in Patients on Hemodialysis

H. Makino, Yoshio Nakamura, Y. Nagake, 2002, Nephron.

Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes.

Yoshio Nakamura, N. Tsugawa, T. Okano, 2007, Diabetes research and clinical practice.

Lymphocytic Panhypophysitis: its Clinical Features in Japanese Cases

A. Shimatsu, Yoshio Nakamura, Y. Kawasaki, 2011, Japanese clinical medicine.

Charge Selectivity of Proteinuria in Diabetic Glomerulopathy

B. Myers, Yoshio Nakamura, Y. Nakamura, 1988, Diabetes.

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

T. Nakayama, N. Inagaki, N. Harada, 2016, Diabetology & Metabolic Syndrome.

[A case of minimal change nephrotic syndrome manifesting acute renal failure in the course of systemic lupus erythematosus].

H. Makino, Yoshio Nakamura, Y. Yamasaki, 2002, Nihon Jinzo Gakkai shi.

Case of type 1 diabetes mellitus following interferon β-1a treatment for multiple sclerosis.

Kenichi Yoshida, Yoshio Nakamura, M. Shimodahira, 2012, Internal medicine.

The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)

H. Makino, T. Miyoshi, Yoshio Nakamura, 2013, Diabetes & vascular disease research.

Increased arterial stiffness in female‐to‐male transsexuals treated with androgen

Yoshio Nakamura, M. Nakatsuka, Yayoi Emi, 2008, The journal of obstetrics and gynaecology research.

High-dose calcium stimulation test in a case of insulinoma masquerading as hysteria

M. Imamura, R. Doi, Yoshio Nakamura, 2002, Endocrine.

Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II

T. Matsuda, H. Sasano, Yoshio Nakamura, 2001, Endocrine.

Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension.

H. Makino, Yoshio Nakamura, M. Kaihara, 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

Calcitonin gene-related peptide as a GH secretagogue in human and rat pituitary somatotrophs

K. Nakao, A. Shimatsu, Yoshio Nakamura, 1998, Brain Research.

Good response of membranous lupus nephritis to tacrolimus.

H. Sugiyama, Y. Maeshima, H. Makino, 2006, Clinical nephrology.

Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.

H. Makino, Yoshio Nakamura, H. Uchida, 2012, Acta medica Okayama.

EFFICIENCY OF TELMISARTAN ON MORNING HOME BLOOD PRESSURE AND ARTERIAL WALL STIFFNESS IN PATIENTS WITH MILD HYPERTENSION: P 544

H. Makino, Yoshio Nakamura, M. Kaihara, 2004 .